“…Nevertheless, it has identified some risk factors like age, gender, or high comorbidity status [9, 13, 15, 16, 18-26, 28, 29]. On the other hand, it is less clear whether clinically modifiable outcomes like, for example, HbA1C [30], or patient characteristics like the body mass index (BMI) [31] may have an own predictive role with regard to the UTI risk in T2DM patients.…”